Literature DB >> 14604564

Communicating science to the public: MMR vaccine and autism.

Paul A Offit1, Susan E Coffin.   

Abstract

Media attention and consequent public concerns about vaccine safety followed publication of a small case-series of children who developed autism after receipt of the measles-mumps-rubella (MMR) vaccine. Many well-controlled studies performed subsequently found no evidence that MMR vaccine causes autism. However, despite these studies, some parents remain concerned that the MMR vaccine is not safe. We will discuss the origins of the hypothesis that the MMR vaccine causes autism, studies performed to test the hypothesis, how these studies have been communicated to the public, and some suggested strategies for how this communication can be improved.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14604564     DOI: 10.1016/s0264-410x(03)00532-2

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  20 in total

1.  Exploring the cost effectiveness of an immunization programme for rotavirus gastroenteritis in the United Kingdom.

Authors:  P K Lorgelly; D Joshi; M Iturriza Gómara; J Gray; M Mugford
Journal:  Epidemiol Infect       Date:  2007-03-05       Impact factor: 2.451

2.  Evaluation of Childhood Vaccine Refusal and Hesitancy Intentions in Turkey.

Authors:  Seda Topçu; Habip Almış; Sevgi Başkan; Mehmet Turgut; Filiz Şimşek Orhon; Betül Ulukol
Journal:  Indian J Pediatr       Date:  2018-06-01       Impact factor: 1.967

Review 3.  Childhood Vaccine Refusal and Hesitancy -Reasons.

Authors:  Anju Aggarwal
Journal:  Indian J Pediatr       Date:  2018-10-23       Impact factor: 1.967

Review 4.  The globalization of risk and risk perception: why we need a new model of risk communication for vaccines.

Authors:  Heidi Larson; Pauline Brocard Paterson; Ngozi Erondu
Journal:  Drug Saf       Date:  2012-11-01       Impact factor: 5.606

5.  Quick assessment of the influence of the Hepatitis B vaccine event on children's vaccination.

Authors:  Chenyan Yue; Xiaojin Sun; Ning Wei; Wenzhou Yu; Fuqiang Cui; Huaqing Wang; Li Li; Lijie Zhang; Guoqing Shi; Zhijie An
Journal:  Hum Vaccin Immunother       Date:  2016-05-31       Impact factor: 3.452

Review 6.  Vaccines for measles, mumps and rubella in children.

Authors:  Vittorio Demicheli; Alessandro Rivetti; Maria Grazia Debalini; Carlo Di Pietrantonj
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

Review 7.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2021-11-22

8.  Mismatches between 'scientific' and 'non-scientific' ways of knowing and their contributions to public understanding of science.

Authors:  Anna Mikulak
Journal:  Integr Psychol Behav Sci       Date:  2011-06       Impact factor: 1.156

Review 9.  Constructing target product profiles (TPPs) to help vaccines overcome post-approval obstacles.

Authors:  Bruce Y Lee; Donald S Burke
Journal:  Vaccine       Date:  2009-09-25       Impact factor: 3.641

10.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2020-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.